{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:19:16Z","timestamp":1790543956286,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T00:00:00Z","timestamp":1520985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1038\/s41409-018-0153-1","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T12:56:02Z","timestamp":1520513762000},"page":"1139-1148","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":123,"title":["Is the use of unrelated donor transplantation leveling off in\n            Europe? The 2016 European Society for Blood and Marrow Transplant activity survey\n            report"],"prefix":"10.1038","volume":"53","author":[{"name":"for the European Society for Blood and Marrow\n                    Transplantation (EBMT)","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob R","family":"Passweg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Baldomero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3858-8180","authenticated-orcid":false,"given":"Grzegorz W.","family":"Basak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Bonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaus","family":"Kr\u00f6ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Kuball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjan","family":"Lankester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Montoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnon","family":"Nagler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Snowden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Styczynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Mohty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,14]]},"reference":[{"key":"153_CR1","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMra052638","volume":"354","author":"EA Copelan","year":"2006","unstructured":"Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med.\n                    2006;354:1813\u201326.","journal-title":"N Engl J Med"},{"key":"153_CR2","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1056\/NEJMp078166","volume":"357","author":"FR Appelbaum","year":"2007","unstructured":"Appelbaum FR. Hematopoietic-cell transplantation at 50. N Engl J\n                    Med. 2007;357:1472\u20135.","journal-title":"N Engl J Med"},{"key":"153_CR3","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/bmt.2015.6","volume":"50","author":"A Sureda","year":"2015","unstructured":"Sureda A, Bader P, Cesaro S, Dreger P, Duarte RF, Dufour C, et al.\n                    Indications for allo- and auto-SCT for haematological diseases, solid tumours\n                    and immune disorders: current practice in Europe, 2015. Bone Marrow Transplant.\n                    2015;50:1037\u201356.","journal-title":"Bone Marrow Transplant"},{"key":"153_CR4","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1001\/jama.2010.491","volume":"303","author":"A Gratwohl","year":"2010","unstructured":"Gratwohl A, Baldomero H, Aljurf M, Pasquini MC, Bouzas LF, Yoshimi\n                    A, et al. Hematopoietic stem cell transplantation: a global perspective. JAMA.\n                    2010;303:1617\u201324.","journal-title":"JAMA"},{"key":"153_CR5","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1016\/S2352-3026(15)00028-9","volume":"2","author":"A Gratwohl","year":"2015","unstructured":"Gratwohl A, Pasquini MC, Aljurf M, Atsuta Y, Baldomero H, Foeken L,\n                    et al. One million haemopoietic stem-cell transplants: a retrospective\n                    observational study. Lancet Haematol. 2015;2:e91\u2013e100.","journal-title":"Lancet Haematol"},{"key":"153_CR6","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/bmt.2010.69","volume":"46","author":"A Gratwohl","year":"2011","unstructured":"Gratwohl A, Baldomero H, Schwendener A, Gratwohl M, Apperley J,\n                    Frauendorfer K, et al. The EBMT activity survey 2008 impact of team size, team\n                    density and new trends. Bone Marrow Transplant.\n                    2011;46:174\u201391.","journal-title":"Bone Marrow Transplant"},{"key":"153_CR7","first-page":"197","volume":"8","author":"A Gratwohl","year":"1991","unstructured":"Gratwohl A. Bone marrow transplantation activity in Europe 1990.\n                    Report from the European Group for Bone Marrow Transplant (EBMT). Bone Marrow\n                    Transplant. 1991;8:197\u2013201.","journal-title":"Bone Marrow Transplant"},{"key":"153_CR8","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1182\/blood-2002-03-0675","volume":"100","author":"A Gratwohl","year":"2002","unstructured":"Gratwohl A, Baldomero H, Horisberger B, Schmid C, Passweg J,\n                    Urbano-Ispizua A. Accreditation Committee of the European Group for Blood and\n                    Marrow Transplantation (EBMT). Current trends in haematopoietic stem cell\n                    transplantation in Europe. Blood. 2002;100:2374\u201386.","journal-title":"Blood"},{"key":"153_CR9","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/bmt.2009.7","volume":"43","author":"A Gratwohl","year":"2009","unstructured":"Gratwohl A, Baldomero H, Schwendener A, Rocha V, Apperley J,\n                    Frauendorfer K, et al. The EBMT activity survey 2007 with focus on allogeneic\n                    HSCT for AML and novel cellular therapies. Bone Marrow Transplant.\n                    2009;43:275\u201391.","journal-title":"Bone Marrow Transplant"},{"key":"153_CR10","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3324\/haematol.2009.015586","volume":"95","author":"A Gratwohl","year":"2010","unstructured":"Gratwohl A, Schwendener A, Baldomero H, Gratwohl M, Apperley J,\n                    Niederwieser D, et al. Changes in use of hematopoietic stem cell\n                    transplantation; a model for diffusion of medical technology. Haematologica.\n                    2010;95:637\u201343.","journal-title":"Haematologica"},{"key":"153_CR11","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/bmt.2014.55","volume":"49","author":"JR Passweg","year":"2014","unstructured":"Passweg JR, Baldomero H, Peters C, Gaspar HB, Cesaro S, Dreger P,\n                    et al. Hematopoietic SCT in Europe: data and trends in 2012 with special\n                    consideration of pediatric transplantation. Bone Marrow Transplant.\n                    2014;49:744\u201350.","journal-title":"Bone Marrow Transplant"},{"key":"153_CR12","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/bmt.2016.20","volume":"51","author":"JR Passweg","year":"2016","unstructured":"Passweg JR, Baldomero H, Bader P, Bonini C, Cesaro S, Dreger P, et\n                    al. Hematopoietic stem cell transplantation in Europe 2014: more than 40000\n                    transplants annually. Bone Marrow Transplant. 2016;51:786\u201392.","journal-title":"Bone Marrow Transplant"},{"key":"153_CR13","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/bmt.2017.34","volume":"52","author":"JR Passweg","year":"2017","unstructured":"Passweg JR, Baldomero H, Bader P, Bonini C, Duarte RF, Dufour C, et\n                    al. Use of haploidentical stem cell transplantation continues to increase: the\n                    2015 European Society for Blood and Marrow Transplant activity survey report.\n                    Bone Marrow Transplant. 2017;52:811\u20137.","journal-title":"Bone Marrow Transplant"},{"key":"153_CR14","unstructured":"World Health Organisation. Transplantation. Geneva: WHO (\n                    http:\/\/www.who.int\/topics\/transplantation\/en\/\n                    \n                  )"},{"key":"153_CR15","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/S1470-2045(14)70245-1","volume":"15","author":"G Cook","year":"2014","unstructured":"Cook G, Williams C, Brown JM, Cairns DA, Cavenagh J, Snowden JA, et\n                    al. High-dose chemotherapy plus autologous stem-cell transplantation as\n                    consolidation therapy in patients with relapsed multiple myeloma after previous\n                    autologous stem-cell transplantation (NCRI Myeloma X Relapse [Intensive trial]):\n                    a randomised, open-label, phase 3 trial. Lancet Oncol.\n                    2014;15:874\u201385.","journal-title":"Lancet Oncol"},{"key":"153_CR16","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/bmt.2010.9","volume":"45","author":"LM Foeken","year":"2010","unstructured":"Foeken LM, Green A, Hurley CK, Marry E, Wiegand T, Oudshoorn M.\n                    Monitoring the international use of unrelated donors for transplantation: the\n                    WMDA annual reports. Bone Marrow Transplant. 2010;45:811\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"153_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcyt.2017.08.009","volume":"20","author":"H Ireland","year":"2017","unstructured":"Ireland H, Gay MHP, Baldomero H, De Angelis B, Baharvand H, Lowdell\n                    MW, et al. The survey on cellular and tissue-engineered therapies in Europe and\n                    neighboring Eurasian countries in 2014 and 2015. Cytotherapy .\n                    2017;20:1\u201320.","journal-title":"Cytotherapy"},{"key":"153_CR18","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1002\/eji.201545552","volume":"45","author":"C Bonini","year":"2015","unstructured":"Bonini C, Mondino A. Adoptive T-cell therapy for cancer: the era of\n                    engineered T cells. Eur J Immunol. 2015;45:2457\u201369.","journal-title":"Eur J Immunol"},{"key":"153_CR19","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1002\/stem.459","volume":"28","author":"J Tolar","year":"2010","unstructured":"Tolar J, Le Blanc K, Keating A, Blazar BR. Concise review: hitting\n                    the right spot with mesenchymal stromal cells. Stem Cells.\n                    2010;28:1446\u201355.","journal-title":"Stem Cells"},{"key":"153_CR20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/bmt.2016.258","volume":"52","author":"JR Passweg","year":"2017","unstructured":"Passweg JR, Baldomero H, Bader P, Bonini C, Cesaro S, Dreger P, et\n                    al. Impact of drug development on the use of stem cell transplantation: a report\n                    by the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow\n                    Transplant. 2017;52:191\u20136.","journal-title":"Bone Marrow Transplant"},{"key":"153_CR21","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1056\/NEJMoa1611750","volume":"376","author":"M Attal","year":"2017","unstructured":"Attal M, Lauwers-Cances V, Hulin C, Leleu X, Caillot D, Escoffre M,\n                    et al. Lenalidomide, bortezomib, and dexamethasone with transplantation for\n                    myeloma. N Engl J Med. 2017;376:1311\u201320.","journal-title":"N Engl J Med"},{"key":"153_CR22","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/S1470-2045(16)30167-X","volume":"17","author":"A Younes","year":"2016","unstructured":"Younes A, Santoro A, Shipp M, Zinzani PL, Timmerman JM, Ansell S,\n                    et al. Nivolumab for classical Hodgkin\u2019s lymphoma after failure of both\n                    autologous stem-cell transplantation and brentuximab vedotin: a multicentre,\n                    multicohort, single-arm phase 2 trial. Lancet Oncol.\n                    2016;17:1283\u201394.","journal-title":"Lancet Oncol"},{"key":"153_CR23","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1212\/WNL.0000000000001329","volume":"84","author":"GL Mancardi","year":"2015","unstructured":"Mancardi GL, Sormani MP, Gualandi F, Saiz A, Carreras E, Merelli E,\n                    et al. Autologous hematopoietic stem cell transplantation in multiple sclerosis:\n                    a phase II trial. Neurology . 2015;84:981\u20138.","journal-title":"Neurology"},{"key":"153_CR24","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1182\/bloodadvances.2017010041","volume":"1","author":"JA Snowden","year":"2017","unstructured":"Snowden JA, Badoglio M, Labopin M, Giebel S, McGrath E, Marjanovic\n                    Z, et al. Evolution, trends, outcomes, and economics of hematopoietic stem cell\n                    transplantation in severe autoimmune diseases. Blood Adv.\n                    2017;1:2742\u201355.","journal-title":"Blood Adv"},{"key":"153_CR25","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","volume":"371","author":"SL Maude","year":"2014","unstructured":"Maude SL, Frey N, Shaw PA, Aplenc R, Barrett DM, Bunin NJ, et al.\n                    Chimeric antigen receptor T cells for sustained remissions in leukemia. N Engl J\n                    Med. 2014;371:1507\u201317.","journal-title":"N Engl J Med"},{"key":"153_CR26","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/bmt.2017.54","volume":"52","author":"JA Snowden","year":"2017","unstructured":"Snowden JA, McGrath E, Duarte RF, et al. JACIE accreditation for\n                    blood and marrow transplantation: past, present and future directions of an\n                    international model for healthcare quality improvement. Bone Marrow Transplant.\n                    2017;52:1367\u201371.","journal-title":"Bone Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0153-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0153-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0153-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:11:47Z","timestamp":1684617107000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-018-0153-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,14]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["153"],"URL":"https:\/\/doi.org\/10.1038\/s41409-018-0153-1","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,14]]},"assertion":[{"value":"14 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}